BioSpace News Archive

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the fourth quarter and full year of fiscal year 2021 on Tuesday, March 8, 2022, at 6:30 a.m. Eastern Time (12:30 Central European Time).

The Nomination Committee prior to the 2022 Annual General Meeting will consist of three members, who shall represent the two shareholders with the highest number of shares who accept the assignment to be part of the Nomination Committee as of December 31, 2021, and the Chairman of the Board.

Innovaccer Inc., the Health Cloud company, today announced it has been listed as a partner vendor of choice in the January 2022 Gartner® report, “Quick Answer: Use FHIR to Jump-Start Clinical Data Integration for U.S. Healthcare Payers.”

Cigna Corporation, a global health service company, announced that John Murabito, longtime Chief Human Resources Officer and current Chief Administrative Officer, will retire on April 1.

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the Freezor™ and Freezor™ Xtra Cardiac Cryoablation Catheters are approved by the U.S. Food and Drug Administration (FDA) and are the only ablation catheters approved to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the appointment by cooptation of Alexandre Lebeaut as an independent Director of the Company*.

Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers, announced preclinical data for SG-5-00455, the Company’s development candidate.

ANGLE plc, a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 6,667 new ordinary shares of £0.10 each in the Company.

Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, announced the hiring of Curtis Tyree, PhD, as Sr. Vice President of Strategy and Business Development.